Mirtazapine: a review of its clinical efficacy and tolerability

被引：36

作者：

Szegedi, A ^{[1
]}

Schwertfeger, N ^{[1
]}

机构：

[1] Univ Med Berlin, Charite, Dept Psychiat, D-14050 Berlin, Germany

来源：

EXPERT OPINION ON PHARMACOTHERAPY | 2005年 / 6卷 / 04期

关键词：

D O I：

10.1517/14656566.6.4.631

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：631 / 641

页数：11

共 50 条

[21] Asenapine review, part II: clinical efficacy, safety and tolerability
Citrome, Leslie
[J]. EXPERT OPINION ON DRUG SAFETY, 2014, 13 (06) : 803 - 830
[22] Clinical Efficacy and Tolerability of Linezolid in Pediatric Patients: A Systematic Review
Chiappini, Elena
Conti, Camilla
Galli, Luisa
de Martino, Maurizio
[J]. CLINICAL THERAPEUTICS, 2010, 32 (01) : 66 - 88
[23] Ciprofloxacin - An updated review of its pharmacology, therapeutic efficacy and tolerability
Davis, R
Markham, A
Balfour, JA
[J]. DRUGS, 1996, 51 (06) : 1019 - 1074
[24] Levosulpiride for Dyspepsia and EmesisA Review of its Pharmacology, Efficacy and Tolerability
G.R. Corazza
M. Tonini
[J]. Clinical Drug Investigation, 2000, 19 : 151 - 162
[25] Levosulpiride for dyspepsia and emesis - A review of its pharmacology, efficacy and tolerability
Corazza, GR
Tonini, M
[J]. CLINICAL DRUG INVESTIGATION, 2000, 19 (02) : 151 - 162
[26] Tizanidine - A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders
Wagstaff, AJ
Bryson, HM
[J]. DRUGS, 1997, 53 (03) : 435 - 452
[27] TizanidineA Review of its Pharmacology, Clinical Efficacy and Tolerability in the Management of Spasticity Associated with Cerebral and Spinal Disorders
Antona J. Wagstaff
Harriet M. Bryson
[J]. Drugs, 1997, 53 : 435 - 452
[28] Drug evaluation - Ticlopidine - A review of its pharmacology, clinical efficacy and tolerability in the prevention of cerebral ischaemia and stroke
Noble, S
Goa, KL
[J]. DRUGS & AGING, 1996, 8 (03) : 214 - 232
[29] Clinical efficacy of Mirtazapine in patients with essential tremor
Bayulkem, K
Efendi, H
Karabas, G
[J]. MOVEMENT DISORDERS, 2002, 17 : S344 - S345
[30] Tolerability and safety aspects of mirtazapine
Nutt, DJ
[J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2002, 17 : S37 - S41

← 1 2 3 4 5 →